<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aberrant activation of canonical Wnt signaling is a hallmark event in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The Dickkopf-1 (DKK1) and Secreted Frizzled Related Protein 1 (SFRP1) genes encode extracellular inhibitors of Wnt signaling that are frequently silenced by promoter hypermethylation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>These methylation events have been identified as prognostic markers of patient outcome and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> subtype in several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> but similar roles in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> have not been comprehensively examined </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, the microsatellite instability (MSI) subtype associates with favorable disease outcome but the molecular events that are responsible remain poorly understood </plain></SENT>
<SENT sid="4" pm="."><plain>Consequently, we quantified promoter methylation status of the Wnt <z:chebi fb="68" ids="48706">antagonist</z:chebi> genes DKK1 and SFRP1 in a large population-based cohort of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> from Ontario (n = 549) and Newfoundland (n = 696) stratified by MSI status </plain></SENT>
<SENT sid="5" pm="."><plain>We examined the association between methylation status and clinicopathological features including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> MSI status and patient survival </plain></SENT>
<SENT sid="6" pm="."><plain>DKK1 and SFRP1 were methylated in 13 and 95% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>In Ontario, DKK1 methylation was strongly associated with MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> after adjustment for age, sex and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location [odds ratio (OR) = 13.7, 95% confidence interval (CI) = 7.8-24.2, P &lt; 0.001] </plain></SENT>
<SENT sid="8" pm="."><plain>Conversely, SFRP1 methylation was inversely associated with MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> after these adjustments (OR = 0.3, 95% CI = 0.1-0.9, P = 0.009) </plain></SENT>
<SENT sid="9" pm="."><plain>Similar results were obtained in Newfoundland </plain></SENT>
<SENT sid="10" pm="."><plain>There were no independent associations with recurrence-free survival </plain></SENT>
<SENT sid="11" pm="."><plain>This is the first large study to identify associations between Wnt <z:chebi fb="68" ids="48706">antagonist</z:chebi> promoter hypermethylation and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> MSI subtype </plain></SENT>
<SENT sid="12" pm="."><plain>These events provide insight into subtype-specific epigenetic mediation of Wnt signaling in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>